Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
Insider Trades
|
Expensive Performer
6356.5000
-34.00
(
-0.53
%)
NSE
Dec 30, 2025
09:34 AM
28.28% Gain from 52W Low
Volume:
10,587
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
29 May 2017, 06:03PM
Insider Trades
6356.50
-0.53%
Divis Laboratories Ltd Q4FY17 results comment
Results Update:
Divi's Laboratories Ltd.
by
HDFC Securities
HDFC Securities
Revenue increased by 9.21% to Rs. 1063.14 Cr in Q4FY17 when compared to the previous quarter.
Divi's Laboratories Ltd. is trading
below its 30 day SMA
of 6422.6
More from Divi's Laboratories Ltd.
Recommended
Market opens flat, Bharat Electronics secures orders worth Rs 569 crore
Trendlyne Marketwatch |
30 Dec 2025, 09:21AM
IPO activity is high on listings, but low on subscriptions
|
29 Dec 2025, 05:02PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022